ZEPP vs FITB vs GRMN vs RF

For growth investors, Garmin Ltd.

(GRMN) is the stronger pick with 15. 1% revenue growth year-over-year, versus -46. 6% for Zepp Health Corporation (ZEPP). Regions Financial Corporation (RF) offers the better valuation at 12. 1x trailing P/E (10. 6x forward), making it the more compelling value choice. Analysts rate Fifth Third Bancorp (FITB) a "Buy" — based on 51 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Regions Financial Corporation (RF) is the cheapest at 12.

1x versus Garmin Ltd. at 27. 9x. On forward P/E, Regions Financial Corporation is actually cheaper at 10. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Regions Financial Corporation wins at 0. 61x versus Garmin Ltd. 's 2. 35x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Garmin Ltd.

(GRMN) delivered a total return of +79. 2%, compared to -66. 4% for Zepp Health Corporation (ZEPP). Over 10 years, the gap is even starker: GRMN returned +558. 6% versus ZEPP's -72. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Regions Financial Corporation (RF) is the lower-risk stock at 1.

08β versus Zepp Health Corporation's 1. 66β — meaning ZEPP is approximately 54% more volatile than RF relative to the S&P 500. On balance sheet safety, Garmin Ltd. (GRMN) carries a lower debt/equity ratio of 2% versus 97% for Fifth Third Bancorp — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Garmin Ltd.

(GRMN) is pulling ahead at 15. 1% versus -46. 6% for Zepp Health Corporation (ZEPP). On earnings-per-share growth, the picture is similar: Regions Financial Corporation grew EPS 18. 7% year-over-year, compared to -1642. 9% for Zepp Health Corporation. Over a 3-year CAGR, GRMN leads at 14. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Garmin Ltd.

(GRMN) is the more profitable company, earning 23. 0% net margin versus -41. 6% for Zepp Health Corporation — meaning it keeps 23. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RF leads at 28. 5% versus -25. 9% for ZEPP. At the gross margin level — before operating expenses — RF leads at 74. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Regions Financial Corporation (RF) is the more undervalued stock at a PEG of 0. 61x versus Garmin Ltd. 's 2. 35x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Regions Financial Corporation (RF) trades at 10. 6x forward P/E versus 177. 0x for Zepp Health Corporation — 166. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FITB: 14. 5% to $56. 50.

In this comparison, RF (3.

8% yield), FITB (3. 5% yield), GRMN (1. 4% yield) pay a dividend. ZEPP does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Regions Financial Corporation (RF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

08), 3. 8% yield, +279. 6% 10Y return). Zepp Health Corporation (ZEPP) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RF: +279. 6%, ZEPP: -72. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ZEPP (Technology) and FITB (Financial Services) and GRMN (Technology) and RF (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ZEPP is a small-cap quality compounder stock; FITB is a mid-cap deep-value stock; GRMN is a mid-cap high-growth stock; RF is a mid-cap deep-value stock. FITB, GRMN, RF pay a dividend while ZEPP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.